E von Wasielewski, H H Sedlacek. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antineoplastic Agents/therapeutic useCancer Care FacilitiesCarcinogensCombined Modality TherapyDrug EvaluationDrug Evaluation, PreclinicalFemaleHumansImmunotherapyMaleNational Institutes of Health (U.S.)Neoplasm MetastasisNeoplasms/etiologyNeoplasms/pathologyNeoplasms/therapyResearchUnited States
Substances: See more » Antineoplastic AgentsCarcinogens
Year: 1986 PMID: 3956405
Source DB: PubMed Journal: Dtsch Med Wochenschr ISSN: 0012-0472 Impact factor: 0.628